Literature DB >> 27218242

Fibrolamellar hepatocellular carcinoma in ascitic fluid: A case report with cytohistological correlation.

Anas Bernieh1, Kristen Adams1, Xuehui Susan Liu1, Rhyne Flowers1, Veena Shenoy1, Mithra Baliga1, Israh Akhtar1.   

Abstract

The fibrolamellar variant of hepatocellular carcinoma (FL-HCC) is distinguished from other hepatocellular carcinoma's (HCC) by its unique clinical and pathological features. Cytological features of this tumor on fine needle aspiration have been described earlier. We report a rare case of a 17-year-old African American male with metastatic FL-HCC, diagnosed by body fluid cytology. The patient presented with ascites and computed tomography (CT) scan revealed multiple omental masses and liver lesions. The fluid sample was obtained along with the omental biopsy and was found positive for metastatic fibrolamellar hepatocellular carcinoma. The fluid cytology showed atypical polygonal cells with enlarged nuclei, prominent nucleoli, and abundant granular cytoplasm. Cytomorphologic features of FL-HCC presenting in body fluids have been rarely described before. This case enriches the cytopathology literature by providing awareness of this tumor presenting as metastasis in body fluids, especially in young individuals with liver lesions. Presence of a concurrent biopsy specimen provided cytohistological correlation, as it remains the gold standard for the accuracy and reliability of cytological diagnoses. Diagn. Cytopathol. 2016;44:757-760.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  ascitic fluid cytology; fibrolamellar hepatocellular carcinoma

Mesh:

Year:  2016        PMID: 27218242     DOI: 10.1002/dc.23509

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  1 in total

1.  Utility of Cytokeratin7 Immunocytochemistry in the Cytopathological Diagnosis of Fibrolamellar Hepatocellular Carcinoma.

Authors:  Rashi Garg; Radhika Srinivasan; Pranab Dey; Priya Singh; Nalini Gupta; Arvind Rajwanshi
Journal:  J Cytol       Date:  2018 Apr-Jun       Impact factor: 1.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.